On ECHEMI
Home > Drugs > Xi'an Yuanda Detian Pharmaceutical Co., Ltd.
Xi'an Yuanda Detian Pharmaceutical Co., Ltd.
  • Founded in:

    2002-12-20
  • Country:

    China China
  • Address:

    No. 9, Chuangxin Road, New Industrial Park, Xi'an High-tech Industrial Development Zone
  • Tax NO.:

    91610131742830863Y
  • Registered Funds:

    82.451 million yuan
  • Website:

  • Email:

Related Drugs
Ozagrel Sodium for Injection
Ozagrel sodium.
Name Description Content CAS NO. Registered Holders
Ozagrel sodium

This product is a thromboxane synthetase inhibitor that can inhibit the production of TXA2, thus having the effects of anti-platelet aggregation and vasodilation. Animal experiments have shown that intravenous administration can reduce plasma TXB2 levels and the Keto-PGF12/TXB2 ratio, inhibit platelet aggregation caused by different inducers, and prevent cerebral infarction caused by the middle cerebral artery in rats.

More

This product is a thromboxane synthetase inhibitor that can inhibit the production of TXA2, thus having the effects of anti-platelet aggregation and vasodilation. Animal experiments have shown that intravenous administration can reduce plasma TXB2 levels and the Keto-PGF12/TXB2 ratio, inhibit platelet aggregation caused by different inducers, and prevent cerebral infarction caused by the middle cerebral artery in rats.

189224-26-8 10
Ozagrel Sodium for Injection
Ozagrel sodium.
Name Description Content CAS NO. Registered Holders
Ozagrel sodium

This product is a thromboxane synthetase inhibitor that can inhibit the production of TXA2, thus having the effects of anti-platelet aggregation and vasodilation. Animal experiments have shown that intravenous administration can reduce plasma TXB2 levels and the Keto-PGF12/TXB2 ratio, inhibit platelet aggregation caused by different inducers, and prevent cerebral infarction caused by the middle cerebral artery in rats.

More

This product is a thromboxane synthetase inhibitor that can inhibit the production of TXA2, thus having the effects of anti-platelet aggregation and vasodilation. Animal experiments have shown that intravenous administration can reduce plasma TXB2 levels and the Keto-PGF12/TXB2 ratio, inhibit platelet aggregation caused by different inducers, and prevent cerebral infarction caused by the middle cerebral artery in rats.

189224-26-8 10
Cold and Heat Clearing Granules
Nepeta spicate, mint, siler, bupleurum, perilla leaf, kudzu root, platycodon, bitter almond, angelica dahurica, bitter herb, reed root. Sucrose and dextrin are auxiliary materials.
Name Description Content CAS NO. Registered Holders
SCHIZONEPETAE SPICA

Not yet clear

More

Not yet clear

0
PEPPERMINT

Not yet clear

More

Not yet clear

0
SAPOSHNIKOVIAE RADIX

Not yet clear

More

Not yet clear

0
Bupleurum

Not yet clear

More

Not yet clear

0
Folia perillae acutae

Not yet clear

More

Not yet clear

0
Puerariae Lobatae Radix

Not yet clear

More

Not yet clear

0
Platycodonis Radix

Not yet clear

More

Not yet clear

0
ARMENIACAE SEMEN AMARUM

Not yet clear

More

Not yet clear

0
Angelicae Dahuricae Radix

Not yet clear

More

Not yet clear

0
CORYDALIS BUNGEANAE HERBA

Not yet clear

More

Not yet clear

0
PHRAGMITIS RHIZOMA

Not yet clear

More

Not yet clear

0
Sucrose

Not yet clear

More

Not yet clear

57-50-1 71
Dextrin

Not yet clear

More

Not yet clear

9004-53-9 50
Wei Ling Granules
Licorice (roasted), cuttlebone, white peony root (fried), atractylodes (fried), Corydalis yanhusuo, and Codonopsis pilosula.
Name Description Content CAS NO. Registered Holders
Licorice (roasted)

0
Cuttlebon(CuttlefishBone)Extract

0
White Peony Root (Fried)

0
Atractylodes macrocephala (fried)

0
Yanhusuo

0
Codonopsis

0
Wei Ling Granules
Licorice (roasted), cuttlebone, white peony root (fried), atractylodes (fried), Corydalis yanhusuo, and Codonopsis pilosula.
Name Description Content CAS NO. Registered Holders
Licorice (roasted)

0
Cuttlebon(CuttlefishBone)Extract

0
White Peony Root (Fried)

0
Atractylodes macrocephala (fried)

0
Yanhusuo

0
Codonopsis

0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.